Skip to content

Author

Rose Chang

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Association of alanine aminotransferase flares with hepatitis B surface antigen loss and clinical outcomes in treated and untreated patients with chronic hepatitis B virus infection: A US retrospective cohort study

Background Previous research has demonstrated the clinical significance of alanine aminotransferase (ALT) flares; however, studies have mostly been in Asian countries or populations, and it remains unclear whether ALT flares during treatment are associated with hepatitis B surface antigen (HBsAg) loss and long-term adv...

M. Drysdale, Eleonora Morais, Rose Chang et al. · 0 citations
Open access Oct 2026

Complicated Urinary Tract Infections Caused by Fluoroquinolone-Non-Susceptible/Trimethoprim-Sulfamethoxazole-Resistant Extended-Spectrum β-Lactamase-Producing Enterobacterales: Patient Characteristics, Resistance Phenotypes, Treatment Patterns, and Clinical Outcomes.

INTRODUCTION Patients with complicated urinary tract infections (cUTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacterales (ESBL-E) not susceptible (NS) to fluoroquinolones (FQ-NS) or resistant (R) to trimethoprim-sulfamethoxazole (TMP/SMX-R) have few effective oral treatment options. METHODS D...

Ryan K. Shields, A. Ackerman, Myriam Drysdale et al. · 0 citations
Open access Sep 2026

When Empiric Therapy Fails: Clinical and Economic Consequences in uUTIs Among US Women

Patients with TF had significantly higher risk of adverse outcomes and greater HCRU than patients without TF, and patients with TF had significantly greater all-cause and UTI-related HCRU.

D. Fromer, Jeffrey J. Ellis, Rose Chang et al. · 0 citations
Review Open access Aug 2026

Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review.

INTRODUCTION The introduction of precision therapy in severe asthma is shifting treatment goals from asthma control towards the more ambitious target of clinical remission. This study evaluated clinical remission in patients with severe asthma receiving mepolizumab in Europe. METHODS A retrospective, physician panel-...

S. Noorduyn, S. Valliant, Steven Gould et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.